We are live on ! Find out more
AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

65 hedge funds and large institutions have $57.6M invested in AVEO Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 5

270% more capital invested

Capital invested by funds: $15.6M → $57.6M (+$42.1M)

220% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 5

86% more funds holding

Funds holding: 35 → 65 (+30)

49% more call options, than puts

Call options by funds: $8.43M | Put options by funds: $5.65M

Holders
65
Holders Change
+30
Holders Change %
+85.71%
% of All Funds
1.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
35
Increased
16
Reduced
5
Closed
5
Calls
$8.43M
Puts
$5.65M
Net Calls
+$2.78M
Net Calls Change
+$2.27M

Top Buyers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
+$9.02M
2
CAM
Cormorant Asset Management
Massachusetts
+$8.52M
3
BlackRock
BlackRock
New York
+$4.03M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.72M
5
Citadel Advisors
Citadel Advisors
Florida
+$2.42M

Top Sellers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
-$363K
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$157K
3
SM
Sabby Management
Florida
-$157K
4
Marshall Wace
Marshall Wace
United Kingdom
-$107K
5
WG
Winton Group
United Kingdom
-$64.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$214K +$244K +38,729 +1,473%
EWM
27
Evercore Wealth Management
New York
$213K – – –
SO
28
STRS Ohio
Ohio
$203K +$249K +39,500 New
ECM
29
ExodusPoint Capital Management
New York
$195K +$239K +37,924 New
AA
30
Ancora Advisors
Ohio
$187K +$229K +36,350 New
BCM
31
Bridgeway Capital Management
Texas
$177K +$216K +34,300 New
N
32
Nuveen
North Carolina
$175K +$214K +33,980 New
GCP
33
GSA Capital Partners
United Kingdom
$172K -$363K -57,525 -63%
Charles Schwab
34
Charles Schwab
California
$166K +$203K +32,209 New
Wells Fargo
35
Wells Fargo
California
$161K +$35.1K +5,557 +22%
MWNA
36
Marshall Wace North America
New York
$147K +$180K +28,498 New
SAMH
37
Shanda Asset Management Holdings
British Virgin Islands
$147K +$181K +28,600 New
AllianceBernstein
38
AllianceBernstein
Tennessee
$129K +$158K +25,000 New
WA
39
WealthTrust Axiom
Pennsylvania
$114K +$107 +17 +0.1%
HSBC Holdings
40
HSBC Holdings
United Kingdom
$110K +$135K +21,372 New
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$106K +$129K +20,512 New
Two Sigma Advisers
42
Two Sigma Advisers
New York
$103K +$127K +20,085 New
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$97K +$119K +18,900 New
Jane Street
44
Jane Street
New York
$84K +$103K +16,312 New
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$69K +$84.1K +13,328 New
WS
46
Wedbush Securities
California
$55K +$67.5K +10,700 New
AIG
47
American International Group
New York
$43K +$52.5K +8,320 New
Deutsche Bank
48
Deutsche Bank
Germany
$32K +$39.5K +6,262 New
UBS Group
49
UBS Group
Switzerland
$26K +$28.6K +4,530 +886%
JP Morgan Chase
50
JP Morgan Chase
New York
$24K +$28.9K +4,576 New
1
2
3

AVEO Hedge Fund Activity: Q2 2020 in Review

65 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q2 2020, worth a combined $57.6M — up 270% from $15.6M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new AVEO positions and 5 closed out — a net gain of 30 holders — while 16 added to existing stakes and 5 trimmed.

The largest buyer was NEA Management Company, adding an estimated $9.02M. The largest seller was GSA Capital Partners, cutting an estimated $363K.

  • 65 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q2 2020, up from 35 in Q1 2020.
  • Funds reported $57.6M of AVEO Pharmaceuticals, Inc. stock for Q2 2020, up 270% quarter-over-quarter.
  • 35 funds opened new AVEO Pharmaceuticals, Inc. positions in Q2 2020 and 5 closed out, a net change of +30 holders.
  • The largest AVEO Pharmaceuticals, Inc. buyer in Q2 2020 was NEA Management Company, an estimated $9.02M added.
  • The largest AVEO Pharmaceuticals, Inc. seller in Q2 2020 was GSA Capital Partners, an estimated $363K sold.

Based on aggregated 13F filings for Q2 2020.